Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Low-Risk SUD 510(k)s Due 18 Months After Final Enforcement Guidance

This article was originally published in The Gray Sheet

Executive Summary

Hospitals and third party reprocessors of single-use devices (SUDs) classified as low risk must submit premarket notifications to FDA within 18 months of the issuance of a final SUD enforcement guidance, according to the agency's draft guidance, "Enforcement Priorities for Single-Use Devices Reprocessed by Third Parties and Hospitals," released Feb. 8.
Advertisement

Related Content

FDA Offers $4,000 To Cover Cost Of Third-Party Review Expenses
FDA Offers $4,000 To Cover Cost Of Third-Party Review Expenses
Canada Examining Single-Use Device Reuse Activity, International Regs
Canada Examining Single-Use Device Reuse Activity, International Regs
Reprocessors, OEMs Will Operate On "Level Playing Field," Feigal Testifies
Reprocessors, OEMs Will Operate On "Level Playing Field," Feigal Testifies
Reprocessors, OEMs Will Operate On "Level Playing Field," Feigal Testifies
Advertisement
UsernamePublicRestriction

Register

MT012954

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel